Pager
Pager
Ciox Health
Developing and commercializing digital therapeutics for patients with unmet medical needs
Click Therapeutics
Ciox Health
Developing and commercializing digital therapeutics for patients with unmet medical needs
Click Therapeutics

Summary

Click Therapeutics develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s digital therapeutics enable change within individuals and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click’s pipeline of innovative digital therapeutics spans multiple therapeutic areas, from psychiatry and chronic pain to cardiometabolic and autoimmune disorders. In addition to its internal pipeline programs, Click has entered into landmark collaboration agreements with Otsuka to develop and commercialize a prescription digital therapeutic for treatment of Major Depressive Disorder (MDD) and with Boehringer Ingelheim to develop and commercialize a prescription-based digital therapeutic to aid in the treatment of schizophrenia.

Our Relationship

As a result of our thematic research into Digital Therapeutics, Health Catalyst Capital invested in Click’s $52 million financing in October 2021 via a senior convertible participating preferred investment. We are excited about the opportunity to work collaboratively with Click’s senior management to help execute the value creation plan.

Learn more at https://www.clicktherapeutics.com/